MR
Mambakkam Rajappa Sivakumar
About Mambakkam Rajappa Sivakumar
Data last updated:
Mambakkam Rajappa Sivakumar was a Director at Paterson Cancer Center Private Limited (2011–2018), Managing Director at Genelab Biotechnologies Private Limited (2006–2020) and Director at Trans Telemedicine Private Limited (from 2011). The companies operate in Healthcare.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Paterson Cancer Center Private Limited U85110TN2000PTC045194 | Director | 28 Jun 2011 | 2000 | ₹2.98 Cr (FY 2025) | Active |
 Genelab Biotechnologies Private Limited U85110TN2006PTC059703 | Managing Director | 03 May 2006 | 2006 | ₹8.40 Cr (FY 2025) | Active |
| Trans Telemedicine Private Limited U74999TN2011PTC079625 | Director | 14 Mar 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mambakkam Rajappa Sivakumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mambakkam Rajappa Sivakumar
Mambakkam Rajappa Sivakumar was first appointed on 03 May 2006 as Managing Director at Genelab Biotechnologies Private Limited. The most recent appointment on record is 28 Jun 2011 at Paterson Cancer Center Private Limited.
Mambakkam Rajappa Sivakumar held 3 earlier board appointments: Paterson Cancer Center Private Limited (Director, 28 Jun 2011 to 25 Mar 2018); Genelab Biotechnologies Private Limited (Managing Director, 03 May 2006 to 10 Nov 2020); Trans Telemedicine Private Limited (Director, from 14 Mar 2011).